Antirobe

Name: Antirobe

Antirobe Food Interactions

Medications can interact with certain foods. In some cases, this may be harmful and your doctor may advise you to avoid certain foods. In the case of clindamycin, there are no specific foods that you must exclude from your diet when receiving this medication.

Inform MD

Before taking clindamycin, tell your doctor about all of your medical conditions. Especially tell your doctor if you:

  • are allergic to clindamycin or to any of its ingredients
  • are allergic to lincomycin (Lincocin)
  • have or have had asthma
  • have or have had eczema
  • have liver problems
  • have kidney problems
  • are pregnant or breastfeeding

Tell your doctor about all the medicines you take including prescription and non-prescription medicines, vitamins, and herbal supplements.

Antirobe and Pregnancy

Tell your doctor if you are pregnant or plan to become pregnant.

The FDA categorizes medications based on safety for use during pregnancy. Five categories - A, B, C, D, and X, are used to classify the possible risks to an unborn baby when a medication is taken during pregnancy.

Clindamycin falls into category B. There are no well-done studies that have been done in humans with clindamycin. In animal studies, pregnant animals were given this medication, and the babies did not show any medical issues related to this medication.

Antirobe Overdose

If you take too much clindamycin, call your healthcare provider or local Poison Control Center, or seek emergency medical attention right away.

If clindamycin is administered by a healthcare provider in a medical setting, it is unlikely that an overdose will occur. However, if overdose is suspected, seek emergency medical attention.

Warnings

Keep out of reach of children. Not for human use.

Adverse Reactions

Side effects occasionally observed in either clinical trials or during clinical use were vomiting and diarrhea.

To report a suspected adverse reaction call 1-800-366-5288.

PRINCIPAL DISPLAY PANEL - 25 mg Capsule Bottle Label

600 Capsules

Antirobe®
clindamycin hydrochloride
capsules, USP

25 mg

Equiv. to 25 mg clindamycin

For Use in Dogs Only

Caution: Federal (USA) law
restricts this drug to use by or on
the order of a licensed
veterinarian.

NADA #120-161, Approved by FDA

Pfizer

PRINCIPAL DISPLAY PANEL - 75 mg Capsule Bottle Label

200 Capsules

Antirobe®
clindamycin hydrochloride
capsules, USP

75 mg

Equiv. to 75 mg clindamycin

For Use in Dogs Only

Caution: Federal (USA) law
restricts this drug to use by or on
the order of a licensed
veterinarian.

NADA #120-161, Approved by FDA

Pfizer

PRINCIPAL DISPLAY PANEL - 300 mg Capsule Bottle Label

Antirobe™
Capsules

clindamycin hydrochloride capsules, USP

300 mg

Equivalent to 300 mg clindamycin
For Use In Dogs Only

Caution: Federal (USA) law restricts this drug to
use by or on the order of a licensed veterinarian.

NADA # 120-161 Approved by FDA

Pharmacia
& Upjohn

Antirobe 
clindamycin hydrochloride capsule
Product Information
Product Type PRESCRIPTION ANIMAL DRUG Item Code (Source) NDC:0009-3043
Route of Administration ORAL DEA Schedule     
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
clindamycin hydrochloride (clindamycin) clindamycin hydrochloride 25 mg
Product Characteristics
Color YELLOW, WHITE Score no score
Shape CAPSULE Size 16mm
Flavor Imprint Code Antirobe;25;MG
Contains     
Packaging
# Item Code Package Description
1 NDC:0009-3043-01 600 CAPSULE (CAPSULE) in 1 BOTTLE, PLASTIC
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
NADA NADA120161 05/31/1984
Antirobe 
clindamycin hydrochloride capsule
Product Information
Product Type PRESCRIPTION ANIMAL DRUG Item Code (Source) NDC:0009-3044
Route of Administration ORAL DEA Schedule     
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
clindamycin hydrochloride (clindamycin) clindamycin hydrochloride 75 mg
Product Characteristics
Color GREEN Score no score
Shape CAPSULE Size 16mm
Flavor Imprint Code Antirobe;75;MG
Contains     
Packaging
# Item Code Package Description
1 NDC:0009-3044-01 200 CAPSULE (CAPSULE) in 1 BOTTLE, PLASTIC
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
NADA NADA120161 05/31/1984
Antirobe 
clindamycin hydrochloride capsule
Product Information
Product Type PRESCRIPTION ANIMAL DRUG Item Code (Source) NDC:0009-3045
Route of Administration ORAL DEA Schedule     
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
clindamycin hydrochloride (clindamycin) clindamycin hydrochloride 150 mg
Product Characteristics
Color BLUE (light blue) , GREEN Score no score
Shape CAPSULE Size 20mm
Flavor Imprint Code Antirobe;150;MG
Contains     
Packaging
# Item Code Package Description
1 NDC:0009-3045-01 100 CAPSULE (CAPSULE) in 1 BOTTLE, PLASTIC
2 NDC:0009-3045-08 100 CAPSULE (CAPSULE) in 1 BLISTER PACK
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
NADA NADA120161 05/31/1984
Antirobe 
clindamycin hydrochloride capsule
Product Information
Product Type PRESCRIPTION ANIMAL DRUG Item Code (Source) NDC:0009-5015
Route of Administration ORAL DEA Schedule     
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
clindamycin hydrochloride (clindamycin) clindamycin hydrochloride 300 mg
Product Characteristics
Color BLUE (Light Blue) Score no score
Shape CAPSULE Size 22mm
Flavor Imprint Code Antirobe;300;MG
Contains     
Packaging
# Item Code Package Description
1 NDC:0009-5015-01 100 CAPSULE (CAPSULE) in 1 BLISTER PACK
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
NADA NADA120161 05/31/1984 05/18/2010
Labeler - Pharmacia and Upjohn Company (829076566)
Establishment
Name Address ID/FEI Operations
Patheon Whitby Inc. 205475333 MANUFACTURE
Establishment
Name Address ID/FEI Operations
Patheon Inc., Toronto Region Operations 243790024 MANUFACTURE
Revised: 05/2010   Pharmacia and Upjohn Company
(web3)